AN2 Therapeutics, Inc.

NASDAQ:ANTX

1.22 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -51.321-64.732-40.956-21.543-13.603-5.635
Depreciation & Amortization 00-0.692000
Deferred Income Tax 000000
Stock Based Compensation 8.3388.4124.3910.9740.040
Change In Working Capital -2.9955.8343.7180.0321.224-0.01
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.6410.5532.4970.4170.081-0.016
Other Working Capital -3.6365.2811.221-0.3851.1430.006
Other Non Cash Items -3.279-2.8020.0770.0536.9753.175
Operating Cash Flow -49.257-53.288-33.462-20.484-5.364-2.486
Investing Activities:
Investments In Property Plant And Equipment 000000
Acquisitions Net 000000
Purchases Of Investments -46.751-132.178-93.836-77.27400
Sales Maturities Of Investments 101.3488.972.06527.2500
Other Investing Activites 00-0.022-0.0500
Investing Cash Flow 54.589-43.278-21.771-50.02400
Financing Activities:
Debt Repayment 000000
Common Stock Issued 084.52970.36678.5353.8368.084
Common Stock Repurchased 00-0.011000
Dividends Paid 000000
Other Financing Activities 0.3720.465-0.01178.5353.83648.504
Financing Cash Flow 0.37284.99470.35578.5353.8368.084
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 5.704-11.57215.1228.027-1.5285.598
Cash At End Of Period 21.35115.64727.21912.0974.075.598